# Epigenetics and MDMA-Assisted Psychotherapy for PTSD

> **NCT06189027** · PHASE3 · COMPLETED · sponsor: **University of Southern California** · enrollment: 45 (actual)

## Conditions studied

- PTSD

## Interventions

- **DRUG:** MDMA
- **BEHAVIORAL:** Psychotherapy

## Key facts

- **NCT ID:** NCT06189027
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-20
- **Primary completion:** 2023-11-01
- **Final completion:** 2024-12-31
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2026-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06189027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06189027, "Epigenetics and MDMA-Assisted Psychotherapy for PTSD". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06189027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*